Key facts
- It has raised $19.8M; the latest was Accelerator/Incubator in May 2025.
- Notable investors include Tech Nation Group, Foresight Group, Henry Carleton, MTIP, Sachin Agrawal.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Hexarad
- ·The full record, as it builds
Funding rounds
No funding rounds for Hexarad are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hexarad
Developer of a healthcare technology platform designed to deliver diagnostic services efficiently while prioritizing patient-centric care. The company's platform integrates image analysis algorithms to interpret medical images and optimizes workflows, including scheduling, assignment, prioritization, and tracking of case progress, enabling radiologists to reduce turnaround times for diagnostic reports, leading to faster treatment decisions and improved patient outcomes.
- Sector
- Healthcare
- HQ
- Harrow, United Kingdom
- Founded
- 2016
- Employees
- 98
- Website
- hexarad.com/
- Ownership
- Privately Held (backing)
Hexarad doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hexarad shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hexarad in its N-PORT filings yet. We sweep new filings monthly.